Antimicrobial synergy between mRNA- and protein-level inhibitors. (Q54485697)

30 May 2018

title

Antimicrobial synergy between mRNA- and protein-level inhibitors. (English)

1 reference

30 May 2018

author name string

Rikard Dryselius

series ordinal

1

1 reference

30 May 2018

Natalia Nekhotiaeva

series ordinal

2

1 reference

30 May 2018

Liam Good

series ordinal

3

1 reference

30 May 2018

language of work or name

English

0 references

publication date

24 May 2005

1 reference

30 May 2018

Journal of Antimicrobial Chemotherapy

published in

1 reference

30 May 2018

volume

56

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

97-103

1 reference

30 May 2018

Mechanisms of action of antimicrobials: focus on fluoroquinolones

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

New (and not so new) antibacterial targets - from where and when will the novel drugs come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Bactericidal antisense effects of peptide-PNA conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Inhibition of Gene Expression inEscherichia coliby Antisense Phosphorodiamidate Morpholino Oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Gene regulation by riboswitches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Nucleic-acid therapeutics: basic principles and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

The future of antisense therapy: combination with anticancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Chemogenomic profiling: identifying the functional interactions of small molecules in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Mechanism of action of trimethoprim and sulphonamides: relevance to synergy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

A genome-wide strategy for the identification of essential genes in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

Identification of antimicrobial targets using a comprehensive genomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI173

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI173

1 reference

30 May 2018

PubMed ID

15914490

1 reference

30 May 2018